Charles Feathers
About Charles Feathers
Charles Feathers serves as the Manager of Process Development at Tenaya Therapeutics, where he has worked since 2022. He has a diverse background in biotechnology, having held various research and development roles at multiple companies.
Work at Tenaya Therapeutics
Charles Feathers has been serving as Manager of Process Development at Tenaya Therapeutics since 2022. His role involves overseeing the development of processes related to therapeutic products. Prior to this position, he held multiple roles within the company, including Senior Research Associate II and Associate Scientist in Process Development. His experience at Tenaya spans several years, contributing to various projects focused on advancing therapeutic solutions.
Previous Experience in Biotechnology
Before joining Tenaya Therapeutics, Charles Feathers worked at several biotechnology firms. He was a Senior Research Associate at Adverum Biotechnologies, Inc. for seven months in 2017. He also served as a Process Development Engineer at Adicet Bio, Inc. from 2017 to 2019. Additionally, he held the position of Research Associate II at Avalanche Biotechnologies, Inc. from 2016 to 2017, gaining valuable experience in research and development within the biotech sector.
Educational Background in Molecular Bioscience
Charles Feathers studied at the Rochester Institute of Technology, where he earned a Bachelor of Science (B.S.) degree in Molecular Bioscience and Biotechnology. His studies spanned from 2011 to 2012, during which he engaged in undergraduate research for eight months. This educational foundation has supported his career in the biotechnology field.
Career Progression in Biotechnology
Charles Feathers has a diverse career trajectory in the biotechnology industry. He began his career as a Molecular Biologist at Complete Genomics Inc., where he worked from 2013 to 2016. His roles evolved over time, leading to positions with increasing responsibility, including his current managerial role at Tenaya Therapeutics. His extensive experience reflects a commitment to advancing biotechnological processes and products.